Inceptor Bio
- Biotech or pharma, therapeutic R&D
Inceptor Bio is a clinical-stage company developing next-generation T cell therapies for solid tumors using our proprietary OUTLAST platform, designed to enhance T cell persistence, fitness, and anti-tumor function in the hostile tumor microenvironment.